ArticleTranslational andrology and urology2023

Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era.

Jiping Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.